Iron Mountain director sells 1,892 shares under plan
IRON MOUNTAIN INC director Pamela M. Arway sold shares in a planned transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IRON MOUNTAIN INC director Pamela M. Arway sold shares in a planned transaction. She completed an open-market sale of 1,892 shares of common stock at $128.97 per share and now holds 40,196 shares directly. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 8, 2025, indicating it was scheduled in advance rather than timed discretionarily.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $.01 per share | 1,892 | $128.97 | $244K |
Footnotes (1)
- F1. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IRM director Pamela M. Arway report on this Form 4?
Was the IRM insider sale by Pamela M. Arway made under a Rule 10b5-1 plan?
Does Pamela M. Arway’s Form 4 transaction involve derivative securities of IRM?
AI-generated analysis. How Rhea-AI works. Not financial advice.